Anavex Life Sciences (AVXL) Change in Accured Expenses (2010 - 2025)
Anavex Life Sciences recorded quarterly Change in Accured Expenses of -$965000.0 in Q4 2025, down 2508.11% quarter-over-quarter from -$37000.0 in Q3 2025, and down 133.31% year-over-year from $2.9 million in Q4 2024.
Anavex Life Sciences' Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$965000.0 for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 133.31% year-over-year to -$965000.0; the TTM figure through Dec 2025 stood at -$4.8 million (down 1177.35% YoY), while the FY2025 annual figure was -$943000.0, up 61.67% from the prior year.
- Change in Accured Expenses came in at -$965000.0 for Q4 2025 at Anavex Life Sciences, down from -$37000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q4 2024 to a low of -$5.6 million in Q2 2025.
- A 5-year average of -$44497.4 and a median of -$23000.0 in 2023 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 32288.89% in 2024 and fell as far as 977.73% in 2024.
- Anavex Life Sciences' Change in Accured Expenses stood at -$164734.0 in 2021, then jumped by 766.53% to $1.1 million in 2022, then slumped by 100.82% to -$9000.0 in 2023, then surged by 32288.89% to $2.9 million in 2024, then tumbled by 133.31% to -$965000.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$965000.0, -$37000.0, and -$5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | -965,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -965,000.00 |
| Dec 31, 2025 | -965,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -5.63 Mn |
| Jun 30, 2025 | -5.63 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | -2.50 Mn |
| Sep 30, 2024 | -2.50 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | -9,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | -837,000.00 |
| Jun 30, 2023 | -837,000.00 |
| Mar 31, 2023 | -220,000.00 |
| Mar 31, 2023 | -220,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 30,953.00 |
| Sep 30, 2022 | 30,953.00 |
| Jun 30, 2022 | 918,433.00 |
| Jun 30, 2022 | 918,433.00 |
| Mar 31, 2022 | -454,652.00 |
| Mar 31, 2022 | -454,652.00 |
| Dec 31, 2021 | -164,734.00 |
| Dec 31, 2021 | -164,734.00 |
| Sep 30, 2021 | 961,340.00 |
| Sep 30, 2021 | 961,340.00 |
| Jun 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.03 Mn |
| Mar 31, 2021 | -197,742.00 |
| Mar 31, 2021 | -197,742.00 |
| Dec 31, 2020 | 499,947.00 |
| Dec 31, 2020 | 499,947.00 |
| Sep 30, 2020 | 347,580.00 |
| Sep 30, 2020 | 347,580.00 |
| Jun 30, 2020 | 389,897.00 |
| Jun 30, 2020 | 389,897.00 |
| Mar 31, 2020 | 242,678.00 |
| Mar 31, 2020 | 242,678.00 |
| Dec 31, 2019 | 820,077.00 |
| Dec 31, 2019 | 820,077.00 |
| Sep 30, 2019 | 402,089.00 |
| Sep 30, 2019 | 402,089.00 |
| Jun 30, 2019 | 133,575.00 |
| Jun 30, 2019 | 133,575.00 |
| Mar 31, 2019 | 143,607.00 |
| Mar 31, 2019 | 143,607.00 |
| Dec 31, 2018 | -92,262.00 |
| Dec 31, 2018 | -92,262.00 |
| Sep 30, 2018 | 637,323.00 |
| Sep 30, 2018 | 637,323.00 |
| Jun 30, 2018 | -207,667.00 |
| Jun 30, 2018 | -207,667.00 |
| Mar 31, 2018 | 618,265.00 |
| Mar 31, 2018 | 618,265.00 |
| Dec 31, 2017 | -785,862.00 |
| Dec 31, 2017 | -785,862.00 |
| Sep 30, 2017 | 2.15 Mn |
| Sep 30, 2017 | 2.15 Mn |
| Jun 30, 2017 | -507,826.00 |
| Jun 30, 2017 | -507,826.00 |
| Mar 31, 2017 | -129,773.00 |
| Mar 31, 2017 | -129,773.00 |
| Dec 31, 2016 | -956,528.00 |
| Dec 31, 2016 | -956,528.00 |
| Sep 30, 2016 | 1.07 Mn |
| Sep 30, 2016 | 1.07 Mn |
| Jun 30, 2016 | -280,606.00 |
| Jun 30, 2016 | -280,606.00 |
| Mar 31, 2016 | 72,110.00 |
| Mar 31, 2016 | 72,110.00 |
| Dec 31, 2015 | -86,297.00 |
| Dec 31, 2015 | -86,297.00 |
| Sep 30, 2015 | 1.24 Mn |
| Sep 30, 2015 | 1.24 Mn |
| Jun 30, 2015 | -160,056.00 |
| Jun 30, 2015 | -160,056.00 |
| Mar 31, 2015 | 124,317.00 |
| Mar 31, 2015 | 124,317.00 |
| Dec 31, 2014 | 101,670.00 |
| Dec 31, 2014 | 101,670.00 |
| Sep 30, 2014 | -316,032.00 |
| Sep 30, 2014 | -316,032.00 |
| Jun 30, 2014 | 35,508.00 |
| Jun 30, 2014 | 35,508.00 |
| Mar 31, 2014 | 57,377.00 |
| Mar 31, 2014 | 57,377.00 |
| Dec 31, 2013 | -79,871.00 |
| Dec 31, 2013 | -79,871.00 |
| Sep 30, 2013 | 41,944.00 |
| Sep 30, 2013 | 41,944.00 |
| Jun 30, 2013 | 123,426.00 |
| Jun 30, 2013 | 123,426.00 |
| Mar 31, 2013 | -19,723.00 |
| Mar 31, 2013 | -19,723.00 |
| Dec 31, 2012 | 320,264.00 |
| Dec 31, 2012 | 320,264.00 |
| Sep 30, 2012 | 423,297.00 |
| Sep 30, 2012 | 423,297.00 |
| Jun 30, 2012 | 349,032.00 |
| Jun 30, 2012 | 349,032.00 |
| Mar 31, 2012 | 521,452.00 |
| Mar 31, 2012 | 521,452.00 |
| Dec 31, 2011 | 987,271.00 |
| Dec 31, 2011 | 987,271.00 |
| Sep 30, 2011 | 17,737.00 |
| Sep 30, 2011 | 17,737.00 |
| Jun 30, 2011 | 289,698.00 |
| Jun 30, 2011 | 289,698.00 |
| Mar 31, 2011 | 710,653.00 |
| Mar 31, 2011 | 710,653.00 |
| Dec 31, 2010 | 111,205.00 |
| Dec 31, 2010 | 111,205.00 |
| Sep 30, 2010 | 293,086.00 |
| Sep 30, 2010 | 293,086.00 |